VEGFA and glaucoma: Another study confirms that compared with the surgery group, the treatment group receiving anti-VEGF combined with anti-glaucoma surgery has a 35% higher success rate at 6 months after surgery, with a significantly lower incidence of complications (Zhou et al., 2023; Guo et al., 2021).